The Consortium for Pediatric Cellular Immunotherapy’s mission is to identify best practices for the development and implementation of innovative immunotherapy clinical trials to, not only, accelerate the ability to offer them to patients, but also to assist investigators throughout the world to more efficiently and effectively develop new cellular immunotherapies.
The Consortium has identified five focus areas that present current challenges to more fully realizing the promise of immune-directed cellular therapies. By establishing and sharing best practices and conducting further research in these areas, the Consortium believes it will accelerate innovation. Areas include:
